Engineering membrane proteins for nuclear medicine: Applications for gene therapy and cell tracking

Quarterly Journal of Nuclear Medicine

Volumn 44, Issue 3, 2000, Pages 224-235

  Bogdanov A A , Jr ^a   Simonova, M ^a   Weissleder, R ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Genetic engineering; Membrane proteins; Radionuclide imaging; Technetium

Indexed keywords

C PEPTIDE; COMPLEMENTARY DNA; CYTOSTATIC AGENT; FLUCYTOSINE; FLUORINE 18; GANCICLOVIR; GLUCEPTATE TC 99M; HYBRID PROTEIN; MEMBRANE PROTEIN; MESSENGER RNA; METALLOTHIONEIN; MONOCLONAL ANTIBODY; N ETHYLMALEIMIDE; PENCICLOVIR; PERTECHNETIC ACID TC 99M; RADIOISOTOPE; TECHNETIUM 99M;

BINDING SITE; CANCER; CELL SURFACE; DRUG CLEARANCE; DRUG HALF LIFE; DRUG INHIBITION; DRUG PROTEIN BINDING; EUKARYOTIC CELL; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENETIC ENGINEERING; GENETIC TRANSFECTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; NUCLEAR MEDICINE; PHENOTYPE; RADIATION DETECTION; REVIEW; SCINTISCANNING; TUMOR CELL;

ANIMAL; GENE THERAPY; GENETIC ENGINEERING; HUMAN; MEMBRANE PROTEINS; METALLOTHIONEIN; PROTEIN BINDING; RADIOPHARMACEUTICALS; RECOMBINANT FUSION PROTEINS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0033789596     PISSN: 11243937     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (74)

1. Radiopharmaceuticals to monitor gene transfer
2. Triumph over mischance: A role for nuclear medicine in gene therapy
3. Imaging gene expression: Principles and assays
4. Imaging the expression of transfected genes in vivo
5. The development of in vivo imaging systems to study gene expression
6. In vivo MR imaging of transgene expression
7. Visualizing gene expression in living mammals using a bioluminescent reporter
8. De novo design of integral membrane proteins
9. Membrane-protein engineering
10. Engineering membrane proteins
11. Guidelines for membrane protein engineering derived from de novo designed model peptides
12. Towards in vivo imaging of gene expression: The engineering of metal-binding sites
13. In vivo localization of diglycylcysteine-bearing synthetic peptides by nuclear imaging of oxotechnetate transchelation
14. Design of metal-binding green flourescent protein variants
15. Oxotechnetate-binding fusion proteins as cell-surface imaging markers of gene expression
16. Herpes simplex virus thymidine kinase as a marker/reporter gene for PET imaging of gene therapy
17. 2 in ovarian carcinoma induced to express the gastrin releasing peptide receptor by adenoviral vector-mediated gene transfer
18. Application of type 2 human somatostatin receptor (hSSTr2) as a reporter for imaging gene transfer
19. Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: A potential method for monitoring clinical gene therapy
20. Monitoring gene therapy with herpes simplex virus thymidine kinase in hepatoma cells: Uptake of specific substrates
21. Imaging of adenoviral-directed herpes simplex virus type 1 thymidine kinase reporter gene expression in mice with radio-labeled ganciclovir
22. Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography
23. Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography
24. Monitoring gene therapy with cytosine deaminase: In vitro studies using tritiated-5-fluorocytosine
25. MR imaging and scintigraphy of gene expression through melanin induction
26. Measuring transferrin receptor gene expression by NMR imaging
27. Radioisotope concentrator gene therapy using the sodium/iodide symporter gene
28. Development and application of herpes simplex virus vectors for human gene therapy
29. In situ use of suicide genes for cancer therapy
30. Photonic detection of bacterial pathogens in living hosts
31. A 'humanized' green fluorescent protein cDNA adapted for high-level expression in mammalian cells
32. Noninvasive assessment of tumor cell proliferation in animal models
33. CCD imaging of luciferase gene expression in single mammalian cells
34. Reporter gene expression for monitoring gene transfer
35. 99mTc-MAG3
36. 99mTc-labelled agents
37. Reduction-mediated technetium-99m labeling of monoclonal antibodies
38. 99mTc labeling of monoclonal antibodies: Radiolabeling and in vitro stability
39. 99mTc
40. Radiolabeling with technetium-99m to study high-capacity and low-capacity biochemical systems
41. Technetium-99m radiolabeling using a phage-derived single-chain Fv with a C-terminal cysteine
42. Radiometal labeling of recombinant proteins by a genetically engineered minimal chelation site: Technetium-99m coordination by single-chain Fv antibody fusion proteins through a C-terminal cysteinyl peptide
43. Single-chain Fv radioimmunotargeting
44. Kinetics of thiol reactions
45. Mechanisms of renal concentration of technetium-99m glucoheptonate
46. Codon usage limitation in the expression of HIV-1 envelope glycoprotein
47. Improved green fluorescence
48. Thiol/disulfide exchange equilibria and disulfide bond stability
49. Primary structure of the Aequorea victoria green-fluorescent protein
50. The molecular structure of green fluorescent protein
51. Requirements for the membrane insertion of signal-anchor type proteins
52. Protein translocation across the endoplasmic reticulum. II. Isolation and characterization of the signal recognition particle receptor
53. Transient involvement of signal recognition particle and its receptor in the microsomal membrane prior to protein translocation
54. Translocation of secretory proteins across the microsomal membrane occurs through an environment accessible to aqueous perturbants
55. Empty site forms of the SRP54 and SR alpha GTPases mediate targeting of ribosome-nascent chain complexes to the endoplasmic reticulum
56. Binding of signal recognition particle gives ribosome/nascent chain complexes a competitive advantage in endoplasmic reticulum membrane interaction
57. A general mechanism for regulation of access to the translocon: Competition for a membrane attachment site on ribosomes
58. TRAM regulates the exposure of nascent secretory proteins to the cytosol during translocation into the endoplasmic reticulum
59. Unregulated exposure of the ribosomal M-site caused by NAC depletion results in delivery of non-secretory polypeptides to the Sec61 complex
60. New insights into signal recognition and elongation arrest activities of the signal recognition particle
61. The nature of topogenic sequences determines the transport competence of topological mutants of neutral endopeptidase-24.11
62. Secretion of a type II integral membrane protein induced by mutation of the transmembrane segment
63. Translocation of neutral endopeptidase 24.11 mutants with deletions of the NH2-terminal cytosolic domain
64. Differential effects of changes in the length of a signal/-anchor domain on membrane insertion, subunit assembly, and intracellular transport of a type II integral membrane protein
65. Multiple determinants direct the orientation of signal-anchor proteins: The topogenic role of the hydrophobic signal domain
66. Targeting of green fluorescent protein expression to the cell surface
67. Transformation of the signal peptide/membrane anchor domain of a type II transmembrane protein into a cleavable signal peptide
68. Pharmacokinetic evaluation of technetium-99-metallothionein-conjugated mouse monoclonal antibody B72.3 in rhesus monkeys
69. A streptavidin-metallothionein chimera that allows specific labeling of biological materials with many different heavy metal ions
70. 99mTc
71. Thrombus imaging with technetium-99m synthetic peptides based upon the binding domain of a monoclonal antibody to activated platelets
72. Chemistry and biochemistry of metallothionein
73. The metallothionein structural motif in gene expression
74. A dual role for COOH-terminal lysine residues in pre-Golgi retention and endocytosis of ERGIC-53